Search
Cardiovascular renal and metabolic diseases infographic
cardiometabolic_retinal_partner_interests.pdf
CardioMetabolic_diseases.pdf
Cardiometabolic_Diseases.pdf
CardioMetabolic_infographic_Update_2021.pdf
CardioMetabolic_Flyer_BIO_2022.pdf
Partnering_In_CARDIOMETABOLIC_0.pdf
Partnering in Cardiometabolic JAN 2023
Partnering in Cardiometabolic JAN 2023 Corporate
Cardio-Renal-Metabolic Infographic Update 2023
Partnering in Cardiometabolic Diseases MAY 2023 Corp
Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf
CardioMetabolic_infographic_FINAL Dec 18 V2.pdf
cardiometabolic_flyer_bio_2019.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
Catherine Alonzo
Catherine Alonzo, Patient Safety Physician, Metabolism, tells us about the importance of drug surveillance.
Discover your hidden talent with BI Open – the new platform for data science enthusiasts
Discover your hidden talent with BI Open – the new platform for data science enthusiasts. For more talent insights, visit our Careers Page.
Generalized pustular psoriasis: Value of community support
Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the importance of knowledge sharing, community support and challenges faced by those living with GPP.
preserved-heart-failure-treatment-approval-europe
preserved-heart-failure-treatment-approval-europe
reduced-heart-failure-treatment-approval-europe
European approval for treatment of adults with heart failure with reduced ejection fraction
emperor-reduced-chmp-positive-opinion
CHMP issues positive opinion for the treatment of adults with heart failure with reduced ejection fraction
emperor-preserved-chmp-positive-opinion
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction